Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsa Int Regulatory News (ASAI)

Share Price Information for Asa Int (ASAI)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
194.50
Ask:
207.00
Spread: 12.50 (6.427%)
Market Cap: £195.62m
ASAI Live PriceLast checked at - London Stock Exchange

Intraday Asa Int Share Chart

CEO succession

24 Feb 2023 07:00

RNS Number : 9120Q
ASA International Group PLC
24 February 2023
 

Press Release

ASA International Group plc announces CEO succession

 

Amsterdam, 24 February 2023 - ASA International Group plc, ('ASA International', the 'Company' or the 'Group'), one of the world's largest international microfinance institutions, today announces its CEO succession as from 15 June 2023.

Mr. Dirk Brouwer, Co-Founder and Chief Executive Officer ("CEO") of ASA International Group plc ("ASA International" or the "Company") informed the Board of his desire to step aside as CEO of ASA International for personal reasons after having founded and managed the Company, for the most part together with the Company's former Chairman, Md. Shafiqual Haque Choudhury, since 2007.

The Board has therefore approved the following succession plan. Mr. Brouwer will remain as CEO until the Annual General Meeting ("AGM") on Thursday 15th June, at which point Ms. Karin Kersten, currently Executive Director, Corporate Development, will be appointed CEO. Ms. Kersten joined ASA International from ABN AMRO Bank in October 2021 and became an Executive Director in April 2022, and in the Board's view is well qualified to lead the Group going forward.

At the same AGM, Mr. Brouwer will step into a new role. He will be appointed as (i) Deputy Chairman of the Board of ASA International and (ii) Special Adviser to the new CEO, the Executive Committee and the broader management team in order to (a) smoothen the path of transition and (b) support the new leadership going forward. In this capacity the Board fully expects Mr. Brouwer to continue to make a significant contribution to the strategic and operational development of the business for the foreseeable future.

 

Dirk Brouwer, Chief Executive Officer, comments:

"After having run ASA International, for the most part together with Shafiq, for more than 15 years, I am very pleased that we have found in Karin a formidable successor to take over the baton as the first female CEO of our company. Karin and I have worked closely together over the last 1 1/2 years, and I am very confident that she will be able to successfully lead the Company going forward in an increasingly more digital world."

 

Karin Kersten, Executive Director, Corporate Development, comments:

"I am honored and excited to have received the confidence of Dirk and the Board to assume the role of Chief Executive Officer of this great company. Together with all ASA International colleagues, I will build on the Company's legacy, with its powerful 'ASA Model', and continue to focus on further increasing financial inclusion of female micro-entrepreneurs across Asia and Africa."

Guy Dawson, Chairman of the Board, comments:

"The Board of Directors is confident that Karin is going to be an excellent successor, who will be able to further strengthen and expand the Company going forward."

 

This announcement contains information that qualified or may have qualified as inside information and is disclosed in accordance with the Market Abuse Regulation (EU) 596/2014 (as it applies in the UK pursuant to the European Union (Withdrawal) Act 2018) ("MAR").

 

Enquiries:

ASA International Group plc

Investor Relations

Mischa Assink ir@asa-international.com

 

About ASA International Group plc

ASA International Group plc (ASAI: LN) is one of the world's largest international microfinance institutions, with a strong commitment to financial inclusion and socioeconomic progress. The company provides small, socially responsible loans to low-income, financially underserved entrepreneurs, predominantly women, across South Asia, South East Asia, West and East Africa.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKNBPOBKDBBB
Date   Source Headline
3rd Jun 20262:14 pmRNSResult of 2026 Annual General Meeting
21st May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20262:56 pmRNSDirector/PDMR Shareholding
5th May 20267:00 amRNSAppointment of Chairman and Board Update
30th Apr 20267:00 amRNSNotice of Annual General Meeting
30th Apr 20267:00 amRNSQ1 2026 Business Update
28th Apr 20267:00 amRNSAppointment of Independent Non-Executive Director
15th Apr 20267:00 amRNSFY 2025 Results
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSDirector/PDMR Shareholding
30th Jan 20261:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSQ4 2025 Trading and Business Update
13th Jan 20263:31 pmRNSHolding(s) in Company
9th Jan 20261:50 pmRNSDirector/PDMR Shareholding
9th Jan 20261:49 pmRNSDirector/PDMR Shareholding
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
19th Dec 202511:15 amRNS2025 Annual General Meeting Update Statement
17th Dec 20253:35 pmRNSAppointment of Non-Executive Director
4th Dec 20257:00 amRNSTrading Update
28th Nov 20259:36 amRNSHolding(s) in Company
10th Nov 20257:57 amRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSCFO Appointment
5th Nov 20255:31 pmRNSHolding(s) in Company
5th Nov 20255:27 pmRNSDirector/PDMR Shareholding
28th Oct 20252:20 pmRNSGrant of Options
27th Oct 20254:44 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSQ3 2025 Business Update
10th Oct 20253:29 pmRNSHolding(s) in Company
10th Oct 20253:28 pmRNSHolding(s) in Company
8th Oct 202512:44 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNS2025 Interim Results
11th Aug 202512:20 pmRNSDirector/PDMR Shareholding
30th Jul 20254:32 pmRNSHolding(s) in Company
29th Jul 202511:12 amRNSHolding(s) in Company
23rd Jul 20259:40 amRNSDirector/PDMR Shareholding
22nd Jul 20257:00 amRNSQ2 2025 Business Update
19th Jun 20252:13 pmRNSResult of AGM
6th Jun 20257:00 amRNSDirectorate Change
20th May 20257:00 amRNSNotice of Annual General Meeting
24th Apr 20257:00 amRNS2024 Results
24th Apr 20257:00 amRNSAppointment of Independent Non-Executive Director
24th Apr 20257:00 amRNSQ1 2025 Business Update
20th Mar 20257:00 amRNSBoard and Leadership Update
10th Mar 202511:18 amRNSHolding(s) in Company
5th Mar 20254:27 pmRNSNotification of Major Holdings
5th Mar 20254:23 pmRNSNotification of Major Holdings
21st Jan 20257:00 amRNSQ4 2024 Trading and Business Update
8th Jan 20252:46 pmRNSDirector Remuneration Update
7th Jan 202512:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.